Cargando…
Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
Background: Lower-grade glioma (LGG) is the most common histology identified in gliomas, a heterogeneous tumor that may develop into high-grade malignant glioma that seriously shortens patient survival time. Recent studies reported that glutamatergic synapses might play an essential role in the prog...
Autores principales: | Ye, Liguo, Xu, Yang, Hu, Ping, Wang, Long, Yang, Ji’an, Yuan, Fan’en, Wang, Yixuan, Zhang, Chunyu, Tian, Daofeng, Chen, Qianxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581158/ https://www.ncbi.nlm.nih.gov/pubmed/34776862 http://dx.doi.org/10.3389/fnmol.2021.720899 |
Ejemplares similares
-
Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
por: Xu, Yang, et al.
Publicado: (2021) -
Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022) -
Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
por: Jiang, Hongxiang, et al.
Publicado: (2022) -
Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
por: Ye, Liguo, et al.
Publicado: (2021) -
ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma
por: Zhang, Chunyu, et al.
Publicado: (2021)